H
Herman Mitchell
Researcher at National Institutes of Health
Publications - 84
Citations - 11523
Herman Mitchell is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Asthma & Population. The author has an hindex of 46, co-authored 84 publications receiving 10816 citations.
Papers
More filters
Journal ArticleDOI
The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma
David L. Rosenstreich,Peyton A. Eggleston,Meyer Kattan,Dean Baker,Raymond G. Slavin,Peter J. Gergen,Herman Mitchell,Kathleen Mcniff-Mortimer,Henry Lynn,Dennis R. Ownby,Floyd J. Malveaux +10 more
TL;DR: The combination of cockroach allergy and exposure to high levels of this allergen may help explain the frequency of asthma-related health problems in inner-city children.
Journal ArticleDOI
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
Wayne J. Morgan,Ellen F. Crain,Rebecca S. Gruchalla,George T. O'Connor,Meyer Kattan,Richard Evans,James W. Stout,George Malindzak,Ernestine Smartt,Marshall Plaut,Michelle Walter,Benjamin Vaughn,Herman Mitchell +12 more
TL;DR: Among inner-city children with atopic asthma, an individualized, home-based, comprehensive environmental intervention decreases exposure to indoor allergens, including cockroach and dust-mite allergen, resulting in reduced asthma-associated morbidity.
Journal Article
The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among innercity children with asthma
David L. Rosenstreich,Peyton A. Eggleston,Meyer Kattan,Dean Baker,Raymond G. Slavin,Peter J. Gergen,Herman Mitchell,Kathleen Mcniff-Mortimer,Henry Lynn,Dennis Randall Ownby,Floyd J. Malveaux +10 more
TL;DR: In this article, the authors found that children who were both allergic to cockroach and exposed to high levels of this allergen had 0.37 hospitalization a year, as compared with 0.11 for the other children (P=0.43) and 2.56 unscheduled medical visits for asthma per year.
Journal ArticleDOI
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
William W. Busse,Wayne J. Morgan,Peter J. Gergen,Herman Mitchell,James E. Gern,Andrew H. Liu,Rebecca S. Gruchalla,Meyer Kattan,Stephen J. Teach,Jacqueline A. Pongracic,James F. Chmiel,Suzanne Steinbach,Agustin Calatroni,Alkis Togias,Katherine M. Thompson,Stanley J. Szefler,Christine A. Sorkness +16 more
TL;DR: When added to a regimen of guidelines-based therapy for inner-city children, adolescents, and young adults, omalizumab further improved asthma control, nearly eliminated seasonal peaks in exacerbations, and reduced the need for other medications to control asthma.
Journal ArticleDOI
Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial
Stanley J. Szefler,Herman Mitchell,Christine A. Sorkness,Peter J. Gergen,George T. O'Connor,Wayne J. Morgan,Meyer Kattan,Jacqueline A. Pongracic,Stephen J. Teach,Gordon R. Bloomberg,Peyton A. Eggleston,Rebecca S. Gruchalla,Carolyn M. Kercsmar,Andrew H. Liu,Jeremy Wildfire,Matthew D Curry,William W. Busse +16 more
TL;DR: Conventional asthma management resulted in good control of symptoms in most participants, and the addition of fraction of exhaled NO as an indicator of control of asthma resulted in higher doses of inhaled corticosteroids, without clinically important improvements in symptomatic asthma control.